Authors
Latest:
The Search for HIV-Associated Neurocognitive Disorder BiomarkersA recent commentary discusses the need to uncover diagnostic and prognostic biomarkers for HIV-associated neurocognitive disorder (HAND).
Latest:
What is on the Horizon for HIV Prevention?A new review in The Lancet HIV discusses the next generation of HIV prevention, called PrEP 2.0.
Latest:
A Look Into the Antimicrobial Stewardship Collaborative of South CarolinaProviders in other states can learn from this multiorganization collaborative that aims to improve antimicrobial utilization and prevent the emergence of antimicrobial resistance across South Carolina.
Latest:
Maintaining Patient Safety During a Water Intrusion in the ORHealth workers had to act quickly when 30,000 gallons of water spilled into the operating room of a level 1 trauma center in Texas.
Latest:
An Update on LenacapavirThis new antiretroviral with a unique mechanism of action may be lifesaving for those with treatment-resistant HIV infection.
Latest:
Researchers Find Drug Combo Works Against Multidrug-Resistant BacteriaRecent research has found that a surprising drug combo might be the key to fighting multidrug-resistant bacteria.
Latest:
Risk for Cancer-Causing Infections Highest in Low- and Middle-Income CountriesDespite the progress that has been made, more research is needed on cancer prevention, hepatitis B, and human papillomavirus vaccines.
Latest:
Contagion's 2024 Top Stories: Hepatitis InfectionsAs 2024 winds down, we're looking back on some of the stories that caught readers' eyes on Contagion related to the variety of hepatitis virus infections.
Latest:
Can Infectious Disease Physicians Help Prevent Violence?About 1.6 million individuals die from violence each year on a global scale—do infectious disease physicians have a role in preventing it?
Latest:
A "Bottom Up" Treatment for Ebola That Could Have Been Used in West AfricaAs sporadic cases of Ebola continue to arise in West Africa, a controversial approach could be utilized to increase survival rates in those who are infected.
Latest:
Treating Outpatient Cystitis in the Era of Antimicrobial ResistanceWhat can clinicians do now that increasing resistance has limited oral treatment options for outpatient cystitis?
Latest:
Examining Real-World Evidence for Oritavancin Use in Gram-Positive InfectionsThe challenges of making formulary and clinical decisions based on regulatory studies are significant and the need for real-world clinical experience is increasingly important.
Latest:
Treating Hepatitis C Virus and HIV Coinfections in Intravenous Drug UsersUnique considerations are called for when caring for intravenous drug users with newly diagnosed HIV/HCV coinfections.
Latest:
The Time for Antifungal Stewardship Programs Is NowThe growing threat of resistance and substantial costs for treating these infections accentuates the need for programs focused on appropriate treatment.
Latest:
Two Years After its FDA Approval, Rebyota Continues to Show Efficacy and SafetyPaul Feuerstadt, MD, FACG, AGAF, discusses what the data says as well as offers insights about what patients can expect and medical peer-to-peer information about the procedure.
Latest:
An Unexpected Meningitis CulpritA team of physicians yields surprising findings in an elderly patient in shock with seizures.
Latest:
The Importance of Maintaining Antibiotic BreakpointsLaboratories that use revised carbapenem breakpoints detect significantly more carbapenem-resistant Enterobacteriaceae than laboratories that use historical ones.
Latest:
Benefits of Azithromycin Outweigh Risks in Elderly Hospitalized with PneumoniaAmong patients aged 65 years or older who are hospitalized with community-acquired pneumonia, azithromycin lowers the risk of 90-day mortality in exchange for slightly increased odds of myocardial infarction compared to other antibiotic regimens.
Latest:
Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest ReportA death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Latest:
About Half of Millennials Are Not Getting Tested For HIVA recent CDC report finds those between 15 and 44 years of age are significantly more likely to have never been tested for HIV.
Latest:
Accurate Data Is Key in Raising Hand Hygiene Compliance and Improving Patient SafetyThe Joint Commission considers hand hygiene the most important intervention for preventing healthcare-associated infections, which are responsible for 75,000 deaths annually.
Latest:
Addressing Weight Gain That Follows Life-Saving Antiretroviral TherapyClinicians must identify when additional pounds cross the line of diminishing return.
Latest:
Taking Action to Address Critical Gaps in Teen ImmunizationAccording to recent data from the Centers for Disease Control and Prevention, millions of Americans aged 13-17 are under-vaccinated against serious infectious diseases.
Latest:
The State of PrEP in 2017: Recent Data and Current ChallengesAlthough a once-daily pill to prevent HIV exists, US populations at highest risk have the lowest rates of usage.
Latest:
Investigational Treatments for Clostridioides difficile InfectionThe high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.
Latest:
Pharmacists Essential to Combatting Vaccine-Preventable DiseasePharmacists have the opportunity to take a lead role in providing education on the importance of vaccines in protecting people from preventable illnesses, according to a session which took place at the American Society of Health-System Pharmacists (ASHP) 54th Midyear Clinical Meeting & Exhibition.
Latest:
Top 5 Contagion® News Articles for the Week of June 25, 2017Measles in Ontario, more endoscope-related infections, a study of postnatal Zika infections, research and development on a river blindness vaccine, and using CRISPR to tackle Zika are the articles that make up this week’s Top 5.
